The UCLA Immunogenetics Center, Department of Pathology, University of California, Los Angeles (www.hla.ucla.edu) is seeking a highly motivated postdoctoral candidate for a translational research project in transplant immunology. The project focuses on mechanisms of transplant rejection with particular emphasis on the discovery and characterization of novel biomarkers of the immune response during solid organ transplant rejection. Continue reading Postdoctoral Research Position in Immunology
A full-time, post-doctoral fellowship is immediately available in the laboratory of Dr. Daniel Lu, UCLA Department of Neurosurgery, to study the neural networks within the spinal cord and leverage this understanding to facilitate recovery of motor function after spinal cord injury (SCI). Continue reading Post-Doctoral Engineering Fellowship at UCLA
A full-time, post-doctoral fellowship position in UCLA laboratory is immediately available. The fellow will be studying the neural networks present within the spinal cord and leveraging this understanding to facilitate recovery of motor function after spinal cord injury. Continue reading Post-Doctoral Neuroscience Fellowship at UCLA
Description: Candidates with a strong background in molecular and cell biology and/or mouse genetics are encouraged to apply. Applicants should have received their Ph.D. within the past 3-4 years. Excellent written and verbal communication skills are required. The postdoctoral fellow will be under the general supervision of the PI/PD, the postdoctoral fellow plans, organizes and coordinates the execution or research projects/studies laboratory diagnosis.
Position Availability: July 1, 2014
The Wadehra Laboratory in the Department of Pathology at the University of California, Los Angeles is seeking an outstanding post-doctoral fellow to work in the area of cancer biology. Our laboratory has 2 main focuses: 1) understanding how tetraspan proteins promote cancer stem cell formation and, 2) creating designer antibodies. Our work is funded for creating novel IgG1 antibodies for breast and ovarian cancers, and we are working with both in vitro and in vivo models.
Application Deadline: August 1, 2014